SEC Form D · filed February 5, 2024
Checkpoint Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Barry F. Salzman · Waltham, MADirectorMichael F. Weiss · Waltham, MADirectorLindsay A. Rosenwald · Waltham, MADirectorNeil F. Herskowitz · Waltham, MADirectorGarrett F. Gray · Waltham, MAExecChristian F. Bechon · Waltham, MADirectorJames F. Oliviero, Iii · Waltham, MAExec · DirectorToyin Ajayi · Dover, DEDirectorBarbara Serrano Sanchez · Madrid, U3DirectorManuel E. Tarrasa Sanchez · Madrid, U3DirectorMarco M. Buhigas Moran · Madrid, U3Exec · DirectorStuart Orgill · San Francisco, CAExecJose M. Moran Adarraga · Madrid, U3DirectorAshley Mayer · Dover, DEDirectorDavid Carew · Toronto, Ontario, CanadaExec · DirectorMaxim D. Crewe · London, United KingdomExecThomas P. Railhac · London, United KingdomDirectorSven Gosta P. Pattersson · London, United KingdomDirectorHiroaki Kobayashi · BALTIMORE, MDDirectorJeffrey Cleland · BALTIMORE, MDDirectorAkihiro Ko · BALTIMORE, MDDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗